Results 1 to 10 of about 1,508 (174)

Delphi Consensus on Reporting Standards in Clinical Studies for Endovascular Treatment of Acute Iliofemoral Venous Thrombosis and Chronic Iliofemoral Venous Obstruction. [PDF]

Circ Cardiovasc Interv, 2023
Acute iliofemoral deep vein thrombosis and chronic iliofemoral venous obstruction cause substantial patient harm and are increasingly managed with endovascular venous interventions, including percutaneous mechanical thrombectomy and stent placement ...
Vedantham S, Gloviczki P, Carman TL, Zelman Lewis S, Schneider PA, Sabri SS, Kolluri R.   +6 more
europepmc   +6 more sources

Role of lower extremity fasciectomy plus fasciotomy for patients with persistent leg pain after stenting for chronic iliofemoral venous obstruction [PDF]

Journal of Vascular Surgery Cases and Innovative Techniques, 2022
Although clinical improvement after stenting for symptomatic iliofemoral venous obstruction has been demonstrated in multiple large studies, a small proportion of patients will experience persistent quality of life–impairing symptoms.
Arjun Jayaraj, MD, Cooper Luke, MS, Jerad Robinson, MSN, Brandi Burr, MSN   +3 more
doaj   +4 more sources

Intravascular lithotripsy as a treatment option for recalcitrant in-stent restenosis in symptomatic patients with chronic iliofemoral venous obstruction [PDF]

Journal of Vascular Surgery Cases and Innovative Techniques
Reinterventions after stenting for chronic iliofemoral venous obstruction have an incidence of approximately 20% to 40% in the literature. The most common reason for this tends to be in-stent restenosis (ISR).
Arjun Jayaraj, MD, FACS
doaj   +3 more sources

Clinical improvement after stenting for chronic iliofemoral venous obstruction: A review of large studies

Vascular Investigation and Therapy, 2022
A review of large studies where patients underwent stenting for symptomatic chronic iliofemoral venous obstruction (CIVO) and had validated clinical and/or quality of life metrics with a follow-up of at least 12 months was performed.
Arjun Jayaraj, Seshadri Raju
doaj   +2 more sources

Indications, technical aspects, and outcomes of stent placement in chronic iliofemoral venous obstruction. [PDF]

J Vasc Surg Venous Lymphat Disord
Iliofemoral venous stent placement (IVS) has evolved to a well-established endovascular treatment modality for chronic iliofemoral venous obstruction (CIVO). Dedicated venous stents gained approval from the US Food and Drug Administration in 2019 and solidified IVS as a defined intervention with clear indications, contraindications, risks, benefits ...
Bai H, Kibrik P, Shaydakov ME, Singh M, Ting W.   +4 more
europepmc   +3 more sources

Prognostic Value of a Classification System for Iliofemoral Stenting in Patients with Chronic Venous Obstruction [PDF]

European Journal of Vascular and Endovascular Surgery
OBJECTIVE This retrospective, multicentre study aimed to assess the prognostic value of a proposed classification system for chronic venous obstruction (CVO) patients undergoing successful interventional procedures.
Avgerinos, Efthymios D, Barbati, Mohammad E, Black, Stephen, Davies, Alun H, Doganci, Suat, Dumantepe, Mert, Hartung, Olivier, International CVO Classification Study Group, Jalaie, Houman, Kucher, Nils, Lichtenberg, Michael, O'Sullivan, Gerard, Piao, Long, Razavi, Mahmood K   +13 more
core   +7 more sources

Outcomes Following Iliac Vein Stenting for Non-Thrombotic Iliac Vein Lesions—A Narrative Review Based on Large Sample Studies [PDF]

Journal of Functional Biomaterials
Objective: May–Thurner syndrome typically refers to symptoms and signs arising from the compression of the left common iliac vein by the right common iliac artery. However, such clinical manifestations can occur in the setting of compression of the right
Arjun Jayaraj
doaj   +2 more sources

Endovenous bypass is an option in symptomatic patients with unsalvageable iliac vein stents [PDF]

Journal of Vascular Surgery Cases and Innovative Techniques
Stent occlusion after stenting for chronic iliofemoral venous disease has an incidence of around 3% to 12% in the literature. The reasons for such occlusion vary, with patient and stent-related factors playing a role.
Arjun Jayaraj, MD, FACS
doaj   +2 more sources

Technique of stent sizing in patients with symptomatic chronic iliofemoral venous obstruction-the case for intravascular ultrasound-determined inflow channel luminal area-based stenting and associated long-term outcomes. [PDF]

J Vasc Surg Venous Lymphat Disord, 2023
Femoroiliocaval stenting has become the standard of care for patients with quality-of-life impairing chronic iliofemoral venous obstruction not responding to conservative measures. Although improvement after stenting has been noted in multiple large studies, sizing of stents has been subjective in nature with a general tendency to use smaller stents ...
Jayaraj A, Thaggard D, Lucas M.
europepmc   +3 more sources

The beneficial role of complex decongestive therapy in patients with symptomatic chronic iliofemoral venous obstruction with phlebolymphedema. [PDF]

J Vasc Surg Venous Lymphat Disord
Phlebolymphedema has been noted to be one of the most common causes of lymphedema in the lower extremity in western societies. Although complex decongestive therapy (CDT) represents the mainstay of lymphedema treatment, its role for phlebolymphedema arising from chronic iliofemoral venous obstruction (CIVO) merits further exploration. We evaluated this
Jayaraj A, Thaggard D.
europepmc   +3 more sources